Prostatis Group LLC Amgen Inc Transaction History

Prostatis Group LLC

$215 Billion
Q2 2023

A detailed history of Prostatis Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Prostatis Group LLC holds 54,976 shares of AMGN stock, worth $17.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

54,976

Previous 5,761 854.28%

Holding current value

$17.6 Million

Previous $1.38 Billion 76.65%

% of portfolio

0.15%

Previous 0.73%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $10.5 Million - $12.5 Million	49,215 Added 854.28%	54,976 $323 Million
Q1 2023 May 22, 2023	SELL	$225.79 - $275.2 $83,542 - $101,824	-370 Reduced 6.03%	5,761 $1.38 Billion
Q4 2022 Mar 28, 2023	BUY	$229.03 - $291.01 $75,808 - $96,324	331 Added 5.71%	6,131 $1.61 Billion
Q4 2022 Mar 23, 2023	BUY	$229.03 - $291.01 $40 Million - $50.8 Million	174,508 Added 16.97%	1,202,895 $1.61 Billion
Q3 2022 Mar 28, 2023	BUY	$224.46 - $253.15 $1.03 Million - $1.16 Million	4,596 Added 381.73%	5,800 $1.31 Billion
Q3 2022 Mar 23, 2023	BUY	$224.46 - $253.15 $229 Million - $258 Million	1,019,914 Added 12037.22%	1,028,387 $1.31 Billion
Q2 2022 Mar 28, 2023	BUY	$230.71 - $256.74 $8,997 - $10,012	39 Added 3.35%	1,204 $293 Million
Q2 2022 Mar 23, 2023	BUY	$230.71 - $256.74 $1.69 Million - $1.88 Million	7,308 Added 627.3%	8,473 $293 Million
Q1 2022 Mar 28, 2023	BUY	$219.27 - $242.57 $2,192 - $2,425	10 Added 0.87%	1,165 $282 Million
Q1 2022 Mar 23, 2023	BUY	$219.27 - $242.57 $2,192 - $2,425	10 Added 0.87%	1,165 $282 Million
Q4 2021 Mar 28, 2023	SELL	$198.88 - $227.6 $6,364 - $7,283	-32 Reduced 2.7%	1,155 $260 Million
Q4 2021 Mar 23, 2023	BUY	$198.88 - $227.6 $1,789 - $2,048	9 Added 0.79%	1,155 $260 Million
Q3 2021 Mar 28, 2023	SELL	$212.27 - $248.7 $1.06 Million - $1.24 Million	-4,985 Reduced 81.31%	1,146 $244 Million
Q3 2021 Mar 23, 2023	SELL	$212.27 - $248.7 $8,703 - $10,196	-41 Reduced 3.45%	1,146 $244 Million
Q2 2021 Mar 28, 2023	SELL	$233.58 - $259.14 $54,424 - $60,379	-233 Reduced 16.41%	1,187 $289 Million
Q2 2021 Mar 23, 2023	SELL	$233.58 - $259.14 $54,424 - $60,379	-233 Reduced 16.41%	1,187 $289 Million
Q1 2021 Mar 28, 2023	BUY	$221.91 - $258.6 $7,323 - $8,533	33 Added 2.38%	1,420 $353 Million
Q1 2021 Mar 23, 2023	BUY	$221.91 - $258.6 $7,323 - $8,533	33 Added 2.38%	1,420 $353 Million
Q4 2020 Mar 28, 2023	BUY	$216.38 - $257.67 $29,427 - $35,043	136 Added 10.87%	1,387 $319 Million
Q4 2020 Mar 23, 2023	BUY	$216.38 - $257.67 $29,427 - $35,043	136 Added 10.87%	1,387 $319 Million
Q3 2020 Mar 28, 2023	BUY	$234.65 - $260.95 $15,486 - $17,222	66 Added 5.57%	1,251 $318 Million
Q3 2020 Mar 23, 2023	BUY	$234.65 - $260.95 $15,486 - $17,222	66 Added 5.57%	1,251 $318 Million
Q2 2020 Mar 28, 2023	BUY	$197.81 - $242.74 $2,373 - $2,912	12 Added 1.02%	1,185 $279 Million
Q2 2020 Mar 23, 2023	BUY	$197.81 - $242.74 $2,373 - $2,912	12 Added 1.02%	1,185 $279 Million
Q1 2020 Mar 28, 2023	SELL	$182.24 - $241.7 $8,565 - $11,359	-47 Reduced 3.85%	1,173 $238 Million
Q1 2020 Mar 23, 2023	SELL	$182.24 - $241.7 $2.2 Million - $2.92 Million	-12,068 Reduced 91.14%	1,173 $238 Million
Q4 2019 Mar 28, 2023	SELL	$189.21 - $243.2 $227 Million - $292 Million	-1,201,675 Reduced 99.9%	1,220 $294 Million
Q4 2019 Mar 23, 2023	BUY	$189.21 - $243.2 $2.51 Million - $3.22 Million	13,241 New	13,241 $298 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Account

Prostatis Group LLC Amgen Inc Transaction History